Medication info
Asipol Tablet (Acyclovir)

Asipol Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 200403329 · Notified 2004.07.08 · Insurance code 652603790

Summary

Main use
Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and varicella
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions involving the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dosage. Younger than 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears and, if possible, within 24 hours of rash onset.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and varicella

  • Genital herpes
  • herpes simplex virus infections of skin and mucosal tissues
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medicine is used for the treatment and prevention of herpes simplex virus infections in skin and mucosal tissues, including primary and recurrent genital herpes. It is also effective in treating herpes zoster virus infections, particularly aiding in pain relief during acute episodes. However, its efficacy for postherpetic neuralgia is not yet conclusively proven. Additionally, it is used for the treatment of chickenpox in children over 2 years of age. This medication is useful in alleviating various symptoms caused by viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions involving the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dosage. Younger than 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears and, if possible, within 24 hours of rash onset.

Precautions

This medication should not be used in patients with a history of allergic reactions to this medicine or its components. Patients with poor kidney function may be more prone to central nervous system side effects when using this medication, so caution is necessary. Patients with impaired liver function should use this medication with care due to the risk of worsening liver function. Children and elderly patients may experience side effects more frequently, so careful administration is required. Rarely, serious allergic reactions, including anaphylactic shock, may occur when using this medication, so symptoms should be closely monitored. If skin rash, fever, vesicles, or hives appear, use should be immediately discontinued and medical attention should be sought. Symptoms such as hair loss, severe dermatitis, and syndromes causing severe damage to skin and mucous membranes may also occur, so caution is needed. Changes in mental state, confusion, hallucinations, seizures, drowsiness, and anxiety may occur, particularly in elderly patients or those with reduced kidney function. Regular urine tests and kidney function tests should be performed as kidney problems can arise. Various side effects, including blood abnormalities, liver dysfunction, and gastrointestinal issues, may occur, so immediate consultation with healthcare professionals is required if symptoms arise. If symptoms do not improve or worsen, especially during treatment for herpes simplex, chickenpox, or herpes zoster, alternative treatment options should be considered. It is effective to administer this medication as soon as possible after symptoms begin, ideally within 5 days for herpes zoster and within 3 days for chickenpox. Patients with weakened immune systems may consider intravenous treatment. Adequate hydration during treatment is important to prevent dehydration and reduce the risk of kidney toxicity. Caution is required when driving or operating machinery as consciousness may be impaired, particularly in patients with reduced kidney function. Interactions may occur with other medications, so any concurrent medications should be reported to healthcare professionals. Women who are pregnant or may become pregnant should carefully consider this medication's potential effects on the fetus. During breastfeeding, this medication may be transmitted through breast milk, so discontinuation of breastfeeding during treatment is advisable. This medication should only be used minimally in children or neonates, as safety has not been established and there may be risks involved. Elderly patients may have heightened blood concentration due to reduced kidney function, so dosage and intervals should be adjusted and administered cautiously. Overdose may lead to kidney damage or central nervous system symptoms, so immediate medical attention should be sought if suspected. In case of overdose, treatments such as dialysis may be needed to lower blood concentrations of the drug. This medication has been reported to have the potential to cause genetic changes at high doses, but no significant issues are known at standard doses.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reactions
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • hives
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • spatial disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • inability to coordinate movements
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function test
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • anorexia
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • hypoproteinemia
  • increased total cholesterol
  • elevated triglycerides
  • increased serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • lethargy
  • confusion
  • hallucinations
  • agitation
  • seizure disorders
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.